34.204.174.110
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Home AAO TED Roundtable Discussion PART 2

Oculoplastics-AAO

Facebook
Twitter
LinkedIn
Email

AAO TED Roundtable Discussion PART 2

Read More
By rd360stg
AAO TED Roundtable Discussion PART 1
December 23, 2021
By rd360stg
Michael Kazim, MD discusses AAO Presentation
December 13, 2021
By rd360stg
Coupled medical and surgical treatment needed for TED
December 1, 2021
By rd360stg
POLL: Do you believe all TED is inflammatory/active?
December 1, 2021
-Advertisement-
-Advertisement-
-Advertisement-
By rd360stg
Teprotumumab is a ‘powerful resource’ for ophthalmologists treating TED
November 30, 2021
By rd360stg
QUIZ: Understanding the Natural History of TED
November 29, 2021
By rd360stg
Teprotumumab adherence rates are high in patients with TED
November 16, 2021
By rd360stg
Teprotumumab-related adverse events common but mild
November 15, 2021
-Advertisement-
-Advertisement-
-Advertisement-
By rd360stg
Healthcare resource utilization high among patients with TED
November 13, 2021
By rd360stg
Case report highlights TED after COVID-19 vaccine in patient with Graves’ Disease history
September 29, 2021
By rd360stg
TED severely impacts quality of life even when disease is stable
September 19, 2021
By rd360stg
Gail Devers Partners with the Graves’ Community to Focus on Thyroid Eye Disease
July 15, 2021
-Advertisement-
-Advertisement-
Videos
All
AAO TED Roundtable Discussion PART 2
28 Dec, 2021

AAO TED Roundtable Discussion PART 1
23 Dec, 2021
Michael Kazim, MD discusses AAO Presentation
13 Dec, 2021
Quizzes
All
QUIZ: Understanding the Natural History of TED
29 Nov, 2021

Polls
All
POLL: Do you believe all TED is inflammatory/active?
01 Dec, 2021

-Advertisement-
-Advertisement-

Contact

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]

QUICK LINKS

Social Links

© 2022 IHM. Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights Reserved
-Advertisement-
-Advertisement-